|
SGOL2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.940300E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.056000E-02 |
| Normal-vs-Stage2 |
6.850100E-02 |
| Normal-vs-Stage3 |
5.968400E-02 |
| Normal-vs-Stage4 |
8.585800E-04 |
| Stage1-vs-Stage2 |
6.523400E-01 |
| Stage1-vs-Stage3 |
9.984200E-01 |
| Stage1-vs-Stage4 |
1.633740E-02 |
| Stage2-vs-Stage3 |
6.571000E-01 |
| Stage2-vs-Stage4 |
1.040180E-01 |
| Stage3-vs-Stage4 |
2.351500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.677600E-03 |
| Normal-vs-AfricanAmerican |
8.029800E-01 |
| Normal-vs-Asian |
1.042180E-01 |
| Caucasian-vs-AfricanAmerican |
5.82889999999336E-05 |
| Caucasian-vs-Asian |
5.560400E-01 |
| AfricanAmerican-vs-Asian |
2.224600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.700900E-03 |
| Normal-vs-Female |
3.955500E-02 |
| Male-vs-Female |
2.367400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.197900E-02 |
| Normal-vs-Age(41-60Yrs) |
1.421600E-02 |
| Normal-vs-Age(61-80Yrs) |
1.084290E-02 |
| Normal-vs-Age(81-100Yrs) |
6.583800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.155400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.200400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.363760E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.617400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.967600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.837700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.250600E-01 |
| Normal-vs-Grade 2 |
1.270360E-02 |
| Normal-vs-Grade 3 |
5.515800E-02 |
| Normal-vs-Grade 4 |
2.375500E-03 |
| Grade 1-vs-Grade 2 |
3.202800E-01 |
| Grade 1-vs-Grade 3 |
7.563600E-01 |
| Grade 1-vs-Grade 4 |
2.947900E-02 |
| Grade 2-vs-Grade 3 |
2.448600E-01 |
| Grade 2-vs-Grade 4 |
7.688000E-02 |
| Grade 3-vs-Grade 4 |
2.409700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.056350E-02 |
| Normal-vs-ccB subtype |
2.139800E-02 |
| ccA subtype-vs-ccB subtype |
8.912400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.724700E-03 |
| Normal-vs-N1 |
9.155500E-04 |
| N0-vs-N1 |
2.646000E-02 |
|
|
